Some of the non-technological barriers outline India may face are Pharmaceutical companies, and government agencies such as the Drug Administration and the National Institutes of Health.
Step-by-step explanation:
- Pharmaceutical companies and government agencies such as the Drug Administration possess large research data.
- If these data were shared more extensively, the resulting research taken from data could improve health spur drug development.
- Data sharing increases public trust in clinical trials.
- Much of this information is never shared.
- Retention of clinical research data by organizations leads to lost opportunities in biomedical experiments and research.
- Barriers to data sharing include concerns about data pool mining and unwarranted litigation.
